14-day Premium Trial Subscription Sign Up For FreeGet Free

Anavex Life Sciences Corp. Stock Forecast NASDAQ:AVXL

$20.44 (5.09%)

Volume: 1M

Closed: Nov 29, 2021

Hollow Logo Score: 4.346

Anavex Life Sciences Corp. Stock Forecast

$20.44 (5.09%)

Volume: 1M

Closed: Nov 29, 2021

Score Hollow Logo 4.346
Which way will AVXL go? Request
Mon, Nov 29, 2021 Buy Candidate Upgraded
Stop-loss: $19.57 (-4.26%)
Key Stats
Beta 1.67
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 75 ] RSI14 is 37 and the stock is currently not being overbought or oversold

On Monday Anavex Life Sciences Corp. stock price gained impressive 5.09%
(Updated on Nov 29, 2021)


Buy candidate since 2021-11-29

The Anavex Life Sciences Corp. stock price gained 5.09% on the last trading day (Monday, 29th Nov 2021), rising from $19.45 to $20.44. , and has now gained 4 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the day the stock fluctuated 6.77% from a day low at $19.95 to a day high of $21.30. The price has been going up and down for this period, and there has been a -8.71% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 323 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $22.83 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 13.99% during the next 3 months and, with a 90% probability hold a price between $20.64 and $27.32 at the end of this 3-month period.

Signals & Forecast

The Anavex Life Sciences Corp. stock holds buy signals from both short and long-term moving averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $19.51 and $19.67. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, November 23, 2021, and so far it has risen 13.75%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss

On the downside, the stock finds support just below today's level from accumulated volume at $18.74 and $17.95. There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Anavex Life Sciences Corp. finds support just below today's level at $18.74. If this is broken, then the next support from accumulated volume will be at $17.95 and $17.63.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $1.35 between high and low, or 6.77%. For the last week, the stock has had a daily average volatility of 10.80%.

Our recommended stop-loss: $19.57 (-4.26%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 3 days ago.)

Is Anavex Life Sciences Corp. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Anavex Life Sciences Corp. stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

Current score: 4.346

Predicted Opening Price for Anavex Life Sciences Corp. of Tuesday, November 30, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price November 30, 2021 Current price
$20.56 $20.44 (Undervalued)
Buy Candidate Upgraded

Remember To Visit Our YouTube Channel

Analyst Ratings

On Nov 25, 2021 "BTIG Research" gave "$34.00" rating for AVXL. The price target was set to $18.99+5.7%.

Volatility and Risk
Daily Average Volatility: 10.80 %
Overall Risk: Very High High Medium Low Very Low
Volatility
10.80 %
Daily Average Volatility
Overall Risk

Very High
High
Medium
Low
Very Low

Support & Resistance

Resistance: $21.38
Price: $20.44
Support: $18.74

AVXL Insider Trading Show all Trades

INSIDER POWER

11.876

Last 100 transactions
Buy: 7 938 491 | Sell: 668 436 (Shares)
Date Action Amount Person Type
Aug 02, 2021 Buy 40 000 Boenisch Sandra Stock Option (Right to Buy)
Aug 02, 2021 Buy 25 000 Velden Claus Vander Stock Option (Right to Buy)
Aug 02, 2021 Buy 25 000 Skarpelos Athanasios Stock Option (Right to Buy)
Aug 02, 2021 Buy 25 000 Donhauser Peter D.o. Stock Option (Right to Buy)
Aug 02, 2021 Buy 25 000 Ma Jiong Stock Option (Right to Buy)
Show all Insider Trades
INSIDER POWER

11.876

Last 100 transactions
Buy: 7 938 491 | Sell: 668 436 (Shares)

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 21.91 7.21 %
21.40 4.69 %
21.08 3.13 %
Current price: 20.44
Support 20.05 -1.92 %
19.73 -3.48 %
19.21 -6.00 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 23.00 12.52 %
22.64 10.76 %
21.38 4.60 %
Current price 20.44
Support 18.74 -8.32%
17.95 -12.18%
17.63 -13.75%

Click to get the best stock tips daily for free!

About Anavex Life Sciences Corp.

Anavex Life Sciences Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of Alzheimer’s disease, other central nervous system diseases, pain, and various cancers. The company’s lead drug candidates include ANAVEX 2-73 and ANAVEX PLUS, a combination of ANAVEX 2-73 with donepezil, which is in a Phase 2a clinical trial for the treatment of Alzheimer’s and other central nervous system ... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT